0001790693-26-000001.txt : 20260106 0001790693-26-000001.hdr.sgml : 20260106 20260106154039 ACCESSION NUMBER: 0001790693-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260106 DATE AS OF CHANGE: 20260106 EFFECTIVENESS DATE: 20260106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Diagnos Inc. CENTRAL INDEX KEY: 0001790693 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-569088 FILM NUMBER: 26511147 BUSINESS ADDRESS: STREET 1: 7005 TASCHEREAU BOULEVARD STREET 2: SUITE 340 CITY: BROSSARD STATE: A8 ZIP: J4Z 1A7 BUSINESS PHONE: 450 678-8882 MAIL ADDRESS: STREET 1: 7005 TASCHEREAU BOULEVARD STREET 2: SUITE 340 CITY: BROSSARD STATE: A8 ZIP: J4Z 1A7 D 1 primary_doc.xml X0708 D LIVE 0001790693 Diagnos Inc. 7005 TASCHEREAU BOULEVARD SUITE 265 BROSSARD A8 QUEBEC, CANADA J4Z 1A7 (450) 678-8882 CANADA (FEDERAL LEVEL) Goth Resources Inc. None Corporation true Marc-Andre Massue 7005 Taschereau Boulevard Suite 265 Brossard A8 QUEBEC, CANADA J4Z 1A7 Executive Officer Philippe Couillard 7005 Taschereau Boulevard Suite 265 Brossard A8 QUEBEC, CANADA J4Z 1A7 Executive Officer Director Robert Dunn 7005 Taschereau Boulevard Suite 265 Brossard A8 QUEBEC, CANADA J4Z 1A7 Director Michael Braeuel 7005 Taschereau Boulevard Suite 265 Brossard A8 QUEBEC, CANADA J4Z 1A7 Director Andre Larente 7005 Taschereau Boulevard Suite 265 Brossard A8 QUEBEC, CANADA J4Z 1A7 Executive Officer Director Yves-Stephane Couture 7005 Taschereau Boulevard Suite 265 Brossard A8 QUEBEC, CANADA J4Z 1A7 Executive Officer Other $1 - $1,000,000 06b false 2025-12-05 true true true true true Each Unit is comprised of 1 common share and 1 common share purchase warrant. Each Warrant entitles the holder thereof to purchase one additional Share at an exercise price of CDN$0.40 per Share for a period of 18 months after the issuance date. false 0 4055841 202254 3853587 The additional $3,853,587 may be received upon the exercise of common share purchase warrants if exercised in the U.S. U.S. dollar amounts are based on the Bank of Canada average rate of exchange reported on December 9, 2025, which was CDN$1.3844=US$1.00. false 1 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Diagnos Inc. /s/ Marc-Andre Massue Marc-Andre Massue Chief Financial Officer 2026-01-06